1. Most Discussed
  2. Gainers & Losers
NEU $1.12

Breakthrough Therapy Status

  1. gxb

    1,043 Posts.
    We all know within 30 days the FDA will make an announcement. NEU have applied for Breakthrough Therapy status and no Australian company has ever been granted BT. Around 30% of BT applications are granted so their is a chance it may not be granted. If this happens I expect some share price weakness however at the same time they will be granted Orphan Drug status for Trofinitide which is just as important but maybe overlooked by the market as the focus will be on the BT. We need to understand sometimes things do not happen as planned thus we cannot panic if BT status is not granted. Lang Walker just purchased options and his holding is at 16% in NEU. I say follow the smart money but we need to be realistic as well.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.